You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,474,535


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,474,535
Title: Dosage and inserter for treatment of erectile dysfunction
Abstract:Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (40) having a shaft with a deformable distal end which forms a dose receiving cavity when an internal piston is retracted relative to the shaft.
Inventor(s): Place; Virgil A. (Kawaihae, HI), Gale; Robert M. (Los Altos, CA), Berggren; Randall G. (Livermore, CA)
Assignee: Vivus, Inc. (Menlo Park, CA)
Application Number:08/093,545
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,474,535: A Detailed Analysis

Introduction

Patent 5,474,535, granted in 1995, is an example of an early patent in the field of technology, and analyzing its scope and claims can provide valuable insights into the evolution of patent law and the patent landscape. This article will delve into the key aspects of this patent, including its claims, the patentability criteria, and the broader context of patent law.

Background of Patent 5,474,535

Patent 5,474,535 was issued on December 12, 1995, and it pertains to a specific technological innovation. To understand its significance, it is crucial to look at the technological context of the time and how patent laws were applied.

Claims and Scope

Claim Structure

The claims of a patent define the scope of the invention and are critical in determining what is protected by the patent. For Patent 5,474,535, each claim must be carefully analyzed to understand what specific aspects of the invention are covered.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial in establishing the broad scope of the patent.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often provide additional details or specific embodiments of the invention[5].

Claim Analysis

To analyze the claims of Patent 5,474,535, one must consider the following:

  • Novelty: Does the claim describe something new and not previously known?
  • Non-obviousness: Is the claimed invention an improvement over existing technology that would not be obvious to a person with ordinary skill in the relevant field?
  • Enablement: Does the patent application provide sufficient detail to allow someone with ordinary skill in the art to make and use the invention without undue experimentation[5].

Patentability Criteria

Subject Matter Eligibility

The patentability of an invention is determined by whether it falls within the categories of subject matter eligible for patent protection. This includes machines, manufactures, and compositions of matter, as well as any improvement thereof. Abstract ideas, laws of nature, and physical phenomena are not eligible unless integrated into a practical application[1].

Recent Guidance on AI and Software Patents

Recent updates from the USPTO, such as the 2024 guidance on AI patents, emphasize the importance of integrating judicial exceptions into practical applications. This means that claims must show how the abstract idea or mathematical model is applied in a way that improves technology or provides a practical benefit[1].

Inventorship and Contribution

Determining True and Only Inventors

The US patent law requires that only the true and only inventors be listed on the patent application. This involves identifying who conceived the idea and reduced it to practice. Incorrect or incomplete identification of inventors can lead to challenges and potentially render the patent unenforceable[2].

Patent Prosecution Process

Filing and Examination

The process of obtaining a patent involves filing a provisional patent application, followed by a non-provisional application within one year. The patent examiner reviews the application for patentability, which can take several years. If the application is not patentable as submitted, arguments and amended claims may be necessary to overcome rejections[5].

Appeals and Final Rejections

If the patent examiner issues a final rejection, the applicant can appeal to the Patent Trial and Appeal Board (PTAB) or the U.S. court system. A successful appeal can lead to claim allowance and the issuance of the patent, while an unsuccessful appeal may result in the abandonment of the patent application[5].

Cost and Commercial Considerations

Financial Implications

The cost of drafting and filing a patent application can be significant, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application. Additional costs are incurred during the patent prosecution process and after the patent is issued. Commercial partners often cover these costs, especially if there is a reasonable likelihood of recovering them through future commercialization[5].

International Patent Landscape

Grace Period and Public Disclosure

In the U.S., there is a one-year grace period for filing a patent application after an enabling public disclosure. However, in most foreign countries, there is no grace period, and public disclosure before filing can result in the loss of patent protection[5].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of claims is crucial for determining the protected invention.
  • Patentability Criteria: Ensuring the invention meets novelty, non-obviousness, and enablement criteria is essential.
  • Inventorship: Correctly identifying the true and only inventors is vital for maintaining the enforceability of the patent.
  • Patent Prosecution: The process involves multiple stages, including filing, examination, and potential appeals.
  • Financial Considerations: The costs associated with patenting can be substantial and are often covered by commercial partners.

FAQs

What are the key elements of a patent claim?

The key elements include novelty, non-obviousness, and enablement. The claim must describe something new, be an improvement over existing technology, and provide sufficient detail to allow someone to make and use the invention without undue experimentation[5].

How does the USPTO determine the patent eligibility of AI-related inventions?

The USPTO focuses on whether the claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

What is the importance of correctly identifying inventors in a patent application?

Correctly identifying the true and only inventors is crucial because incorrect or incomplete identification can lead to challenges and potentially render the patent unenforceable[2].

What is the typical cost of obtaining a U.S. patent?

The cost of drafting and filing a U.S. non-provisional patent application can range from $8,000 to $20,000, with additional costs incurred during the patent prosecution process and after the patent is issued[5].

How does the patent landscape differ internationally?

In the U.S., there is a one-year grace period for filing a patent application after an enabling public disclosure, but in most foreign countries, there is no grace period, and public disclosure before filing can result in the loss of patent protection[5].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims Research Dataset - USPTO
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
  5. Intellectual Property Protection - KU Office of Research

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,474,535

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,474,535

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 173603 ⤷  Subscribe
Australia 655420 ⤷  Subscribe
Australia 7856391 ⤷  Subscribe
Canada 2040914 ⤷  Subscribe
Canada 2352552 ⤷  Subscribe
Germany 69130529 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.